Delving into the Latest Updates on Virginia Technologies, Inc. with Synapse

Overview

Tags

Nervous System Diseases

Immune System Diseases

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

SPNS2(sphingolipid transporter 2)	1

Eco-friendly navigation (a.k.a. eco-routing) finds a route from A to B in a road network that minimizes the greenhouse gas (GHG) emission or fuel/energy consumption of the traveling vehicle. As road transport is a major contributor to GHG emissions, eco-routing has received considerable research attention in the past decade, mainly on two research themes: (1) developing models to estimate emissions or fuel/energy consumption of vehicles; and (2) developing algorithms to find eco-friendly routes for a vehicle. There are some excellent literature reviews that cover the existing estimation models. However, there is no literature review on eco-friendly route-planning algorithms. This article fills this gap and provides a systematic literature review in this area. From mainstream online databases, we obtained 2,494 articles and shortlisted 76 articles using our exclusion criteria. Accordingly, we establish a holistic view of eco-routing systems and define five taxonomies of estimation models, eco-routing problems and algorithms, vehicle types, traffic, and road network characteristics. Concerning the taxonomies, we categorize and review the shortlisted articles. Finally, we highlight research challenges and outline future directions in this important area.

01 Jan 2025·Journal of Fluids Engineering

Effects of Tire Attributes on the Aerodynamic Performance of a Generic Car–Tire Assembly

Author: Rath, Shubham ; Untaroiu, Alexandrina

AbstractThe effect of tires on the overall aerodynamic drag in a car–tire assembly has been studied and deemed considerable from past studies. It has been shown that it is important to understand how the vehicle body and the tires influence the flow structures generated. Previous studies focused on the tire attributes that have an impact on the aerodynamic performance of the vehicle. These tire attributes, however, have not been studied extensively. This paper studies the impact that specific tire attributes have on the overall aerodynamic drag on the vehicle through a systematic sensitivity study. In this study, the DrivAer model is used due to the extensive research that has been done on the model. A baseline computational fluid dynamics model of the tire–vehicle assembly of the DrivAer model is simulated using ansysfluent in the open road domain to understand the flow structures around the body of the vehicle. Simulations are done on the fastback configuration of the DrivAer model with a smooth underbody. Coefficient of drag and coefficient of pressure results from the simulation are validated from experimental data. Data from the simulations and design of experiments are used to quantitatively compare the drag contribution of different parameters of the tire. The sensitivity analysis of the tire–vehicle assembly model performed gives a better insight into the modeling techniques that can be used on a car–tire assembly, as well as the impact of the parameters that could be selected for future tire model optimization.

100 Deals associated with Virginia Technologies, Inc.

Login to view more data

100 Translational Medicine associated with Virginia Technologies, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

Login to view more data